Frogs Fight Back From Fungal Attack

A decade after chytridiomycosis killed scores of amphibians in Panama, some species are recovering. New research indicates why.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Speckled glass frog in PanamaDOUGLAS WOODHAMSIn Panama, between 2004 and 2007, an outbreak of the amphibian disease chytridiomycosis resulted in countless salamander and frog fatalities. But certain species have since recovered, despite the continued presence of the pathogenic fungus responsible for the die-off. An investigation into both the pathogen and its hosts, reported in Science today (March 29), reveals that while the fungus remains as virulent as ever, the surviving host species are less susceptible.

“I see this as a fundamental discovery, and one that is positive and I am very optimistic about,” says Peter Daszak, president of EcoHealth Alliance in New York, a nonprofit organization dedicated to protecting wildlife and public health from disease. “What the paper says is, there is hope that natural evolutionary processes will lead to some populations bouncing back. It’s very good news.”

The fungus Batrachochytrium dendrobatidis, which causes chytridiomycosis, infects the skin of amphibians, and so perturbs the animals’ osmotic regulation. The resulting imbalance of body fluids leads to organ failure and death. First identified in Australia and Central America in 1998, the disease has wreaked havoc across the globe, decimating species along the way, in part because of the movement of amphibians by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies